The foundation of a specialty insurance broker’s work is the thorough knowledge of an industry completely separate from their own.
61 - 70 of 224 items [Currently showing News & Events]
Max Chilton, No. 8 Gallagher Ganassi driver, knew he was facing a challenging adjustment as a 2016 rookie in the Verizon IndyCar Series.
Minnesota Governor Mark Dayton appointed eight people, including Dr. James Fox, Public Sector Compensation Consulting Practice Leader of the Benefits & HR Consulting division of Arthur J. Gallagher & Co., to the state’s Compensation Council.
As 2016 comes to a close, join us as our panel, including Adam Cottini of AJG and Dave Lewison of AmWINS, discusses cyber risk trends that emerged this past year, derived from our proprietary database of more than 30,000 cyber events.
"We are pleased to renew our partnership with motorsports leader Chip Ganassi Racing in the 2017 Verizon IndyCar Series," said Deborah M. Hecht, Vice President – Global Brand Marketing and Sponsorships.
BREAKING NEWS: Injunction Temporarily Blocks Update to FLSA Overtime Rule—Action Items Employers Should Consider Now
Yesterday, November 22, 2016, a federal court judge in Texas issued an injunction temporarily blocking the proposed update to the U.S Department of Labor’s new federal overtime rule. Learn how this news may impact your organization.
Phil Norton received the 2016 Founders Award at the Professional Liability Underwriting Society (PLUS) conference in Chicago.
Discover the magic of Chicago’s mysterious 1893 World’s Fair through the eyes of a child in the Joffrey’s astounding new Nutcracker—brilliantly reimagined by Tony Award-winning Choreographer, Wheeldon. Be part of dance history as we celebrate our beloved city and unlock a world of wonder for the 21st century. An electrifying holiday tale that will leave you breathless.
The generic drug industry is facing criminal investigation following federal suspicion of price collusion. PBMs may become more affordable as a result. Take this opportunity to speak to a Gallagher consultant about controlling your organization’s drug spends.